FindTrial
Sign In

WATCHMAN Left Atrial Appendage Closure

DEVICE3 trials

Sponsors

Boston Scientific Corporation, Abbott Medical Devices, Inova Health Care Services

Conditions

Left Atrial Appendage ClosurePatients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, StrokeStrokeWATCHMAN Device Implantation

Unknown Phase

Registry on WATCHMAN Outcomes in Real-Life Utilization
CompletedNCT01972282
Boston Scientific CorporationPatients With Atrial Fibrillation at Risk for Thrombus Formation, Thromboembolism, Stroke
Start: 2013-10-28End: 2018-01-04Updated: 2019-05-07
AMPLATZER™ Amulet™ LAA Occluder Trial
CompletedNCT02879448
Abbott Medical DevicesStroke
Start: 2016-08-24End: 2024-05-24Updated: 2025-02-26
The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial
CompletedNCT03040622
Inova Health Care ServicesLeft Atrial Appendage Closure, WATCHMAN Device Implantation
Start: 2017-03-01End: 2019-12-31Updated: 2024-03-29

Related Papers

Incidence, Predictors, Management, and Clinical Impact of Major Bleeding Following Left Atrial Appendage Occlusion: The Amulet IDE Randomized Clinical Trial.
2026-03-25
Characterization and Clinical Outcomes of High-Risk Device-Related Thrombus in the Amulet IDE Trial.
2025-04-09
5-Year Results From the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial.
2024-11-1812 citations
Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial
EP Europace2024-07-0113 citations
Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory.
2024-03-135 citations
Mechanisms, predictors, and evolution of severe peri-device leaks with two different left atrial appendage occluders
EP Europace2023-08-0226 citations
3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE).
2023-08-0122 citations
Peridevice Leak After Transcatheter Left Atrial Appendage Occlusion: An Analysis of the Amulet IDE Trial.
2022-11-0152 citations
Sex Differences in Safety and Effectiveness of LAAO: Insights From the Amulet IDE Trial.
2022-10-1211 citations
Incidence, Predictors, and Clinical Outcomes of Device-Related Thrombus in the Amulet IDE Trial.
2022-09-2826 citations
Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial
Circulation2021-08-30357 citations
Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case-control study.
2020-10-0112 citations
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology
Circulation Arrhythmia and Electrophysiology2019-04-01269 citations